Sutro Biopharma Inc (STRO)
3.83
-0.11
(-2.79%)
USD |
NASDAQ |
May 03, 16:00
3.80
-0.03
(-0.78%)
Pre-Market: 08:02
Sutro Biopharma Price to Book Value: 1.969 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.969 |
| May 02, 2024 | 2.025 |
| May 01, 2024 | 1.922 |
| April 30, 2024 | 1.745 |
| April 29, 2024 | 1.809 |
| April 26, 2024 | 1.758 |
| April 25, 2024 | 1.758 |
| April 24, 2024 | 1.784 |
| April 23, 2024 | 1.912 |
| April 22, 2024 | 1.938 |
| April 19, 2024 | 1.866 |
| April 18, 2024 | 1.938 |
| April 17, 2024 | 1.953 |
| April 16, 2024 | 2.025 |
| April 15, 2024 | 2.128 |
| April 12, 2024 | 2.128 |
| April 11, 2024 | 2.313 |
| April 10, 2024 | 2.179 |
| April 09, 2024 | 2.256 |
| April 08, 2024 | 2.436 |
| April 05, 2024 | 2.508 |
| April 04, 2024 | 2.529 |
| April 03, 2024 | 2.124 |
| April 02, 2024 | 2.124 |
| April 01, 2024 | 2.222 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.358 |
| March 27, 2024 | 2.057 |
| March 26, 2024 | 1.744 |
| March 25, 2024 | 1.364 |
| March 22, 2024 | 1.427 |
| March 21, 2024 | 1.456 |
| March 20, 2024 | 1.419 |
| March 19, 2024 | 1.447 |
| March 18, 2024 | 1.594 |
| March 15, 2024 | 1.676 |
| March 14, 2024 | 1.635 |
| March 13, 2024 | 1.859 |
| March 12, 2024 | 1.806 |
| March 11, 2024 | 1.818 |
| March 08, 2024 | 1.904 |
| March 07, 2024 | 1.957 |
| March 06, 2024 | 1.916 |
| March 05, 2024 | 1.851 |
| March 04, 2024 | 1.953 |
| March 01, 2024 | 2.018 |
| February 29, 2024 | 2.002 |
| February 28, 2024 | 2.075 |
| February 27, 2024 | 2.144 |
| February 26, 2024 | 1.959 |
| February 23, 2024 | 1.843 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7263
Minimum
Jun 16 2022
4.48
Maximum
Dec 17 2020
2.152
Average
1.926
Median
Nov 23 2022
Price to Book Value Benchmarks
| AnaptysBio Inc | 8.074 |
| ABVC BioPharma Inc | 1.360 |
| Reviva Pharmaceuticals Holdings Inc | 15.62 |
| Flora Growth Corp | 2.820 |
| Journey Medical Corp | 3.614 |
Price to Book Value Related Metrics
| PS Ratio | 1.499 |
| Price | 3.83 |
| Earnings Yield | -46.48% |
| Market Cap | 294.61M |